The study concluded that the rate of PSA detection in localized recurrent prostate cancer with 68Ga-PSMA-11 PET was significantly improved, demonstrating the effectiveness of this imaging modality in detecting recurrent disease at various PSA levels (23). This evidence concerns the gene FOLH1 and Familial prostate cancer.